{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "document", "Document"], "kwargs": {"metadata": {"source": "/home/guanzhideng145/research/ip_portal/patent_kg/patents/724-US10,975,364(Active) re (Done on website already).pdf"}, "page_content": "G. 4B is a bar graph showing the percentage of edited reads detected by GUIDE-Seq at on-target site (in green) and off-target sites (ordered by the number of mismatches from 1 to 7) among total edited reads by each SaCas9 modified protein.\n\nFIG. 1F is a bar graph showing the percentage of indels on human endogenous site EMX1_1 in HEK293T cells using wild-type SaCas9 (WT), single amino acid substitu- tion SaCas9 modified proteins R245A, N413A, N419A and. R654A, and a no-Cas9 negative control (NC).\n\nFIG. 5A is a venn diagram comparing the number of off-target sites between a modified protein comprising muta- tions at E782, N968 and R1015 positions (indicated as \u201cKKH\u201d in the figure) and a modified protein with mutations at E782, N968, R1015, R245, N413, N419 and R654 posi- tions comprising an amino acid sequence as defined in SEQ ID NO: 4 (KKH-SaCas9-HF, indicated as KKH-HF in the figure) when targeting six sites including EMX1 6\uff0c RUNX1_13, RUNX1_14, FANCF_10, \u00a9 FANCF_13, VEGFA_8 with canonical NNGRRT PAM.\n\nFIG. 1G shows human cell EGFP disruption activities o wild-type SaCas9 (WT) and SaCas9 modified proteins R245A, N413A, N419A and R654A using target protospacer matched or mis-matched gRNA.\n\nFIG. 2A is a bar graph showing the percentage of edited reads detected by GUIDE-seq at on-target site (green) and off-target sites (ordered by number of mismatches from 1 to 7) among total edited reads by VVT SaCas9 and SaCas9 modified proteins R245A, N413A, N419A and R654A at EMX1_6.", "type": "Document"}}